Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event

v3.2.0.727
Subsequent Event
6 Months Ended
Jun. 30, 2015
Subsequent Event [Abstract]  
Subsequent Event
(6)
Subsequent Events

On July 31, 2015 we closed an upsized $15.5 million direct placement of registered common stock with institutional investors, including Soros Fund Management and Perceptive Life Science Fund, and two members of the Board of Directors. The financing is comprised of 2.83 million shares of common stock at a price of $5.50 per share.